Lyme disease was recognized as a separate entity in 1975 because of close geographic clustering of affected children in Lyme, Connecticut, with what was thought to be juvenile rheumatoid arthritis. It then became apparent that Lyme disease is a complex, multisystem disorder. The illness usually begins with erythema migrans (stage 1), and is sometimes followed by meningitis, peripheral neuritis, or carditis (stage 2), or arthritis (stage 3). Although usually intermittent, the arthritis may become chronic, with erosion of cartilage and bone. Erythema chronicum migrans (ECM) was recognized in Europe in 1909, and this lesion was first linked to subsequent neurologic involvement in 1922. There, the neurologic abnormalities have been called different names, including Bannwarth's syndrome, chronic meningitis, and tick-borne meningopolyneuritis (Garin-Bujadoux, Bannwarth). Both arthritis and carditis following ECM have now been described in Europe, but they are rare. Conversely, two additional entities-lymphocytoma and acroder:natitis chronica atrophicans-have been linked to ECM and Ixodes ricinus tick bites in Europe, but an association with tick bites has not been recognized in the United States. In general, the disease seems more virulent in America-multiple skin lesions are more common, headache occurs more often with the meningitis, and arthritis is a frequent feature of the disease-but the basic outlines of the illness are similar both here and abroad. As is typical of other spirochetal infections, Lyme disease occurs in stages, with remissions and exacerbations and different clinical manifestations at each stage. For patients with early Lyme disease, tetracycline is the treatment of choice, then penicillin, and finally erythromycin. High-dose intravenous penicillin is effective for the later stages of Lyme disease. Studies of antibiotic susceptibilities in vitro suggest that oral antibiotic regimens may not always attain blood levels necessary to kill the spirochete.
First, although the exact frequency of the illness is unknown, it is clear that hundreds of new cases of Lyme disease occur each year. Thus, it is necessary for physicians to know how to diagnose and treat the infection. For public health officials, it is important to conduct surveillance, provide serologic support, disseminate information, and to consider methods of tick control. Second, Lyme disease has similarities to several immune-mediated disorders of unknown etiology including rheumatoid arthritis. In the study of these diseases, Lyme disease has the advantage that the causative agent is known. Thus, it is hoped that efforts to understand the pathogenesis of Lyme arthritis may help in the understanding of other arthritides.
